New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
10:02 EDTSTM, MPO, JNJ, OSK, MSFT, HTWR, WFM, MIICF, MDT, ENB, OFC, CIB, GLW, ANFGY, BEPOn The Fly: Analyst Downgrade Summary
Antofagasta (ANFGY) downgraded to Hold from Buy at Canaccord... Bancolombia (CIB) downgraded to Neutral from Overweight at JPMorgan... Brookfield Renewable (BEP) downgraded to Neutral from Outperform at Credit Suisse... Corning (GLW) downgraded to Hold from Buy at Stifel... Corporate Office Properties (OFC) downgraded to Neutral from Buy at ISI Group... Enbridge (ENB) downgraded to Neutral from Outperform at Credit Suisse... HeartWare (HTWR) downgraded to Sell from Neutral at Goldman... Johnson & Johnson (JNJ) downgraded to Hold from Buy at Jefferies... Medtronic (MDT) downgraded to Neutral from Overweight at JPMorgan... Microsoft (MSFT) downgraded to Hold from Buy at Deutsche Bank... Midstates Petroleum (MPO) downgraded to Hold from Buy at MLV & Co... Millicom (MIICF) downgraded to Sell from Hold at Berenberg... Oshkosh (OSK) downgraded to Accumulate from Buy at Global Hunter... STMicroelectronics (STM) downgraded to Sell from Neutral at UBS... Whole Foods (WFM) downgraded to Hold from Buy at BB&T...
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
November 18, 2015
16:01 EDTMSFTOptions Update; November 18, 2015
iPath S&P 500 VIX Short-Term Futures down 1.39 to 19.44. Option volume leaders: AAPL NBG TGT NFLX F FB QCOM SUNE GPRO MSFT
14:49 EDTMSFTEarnings Watch: Salesforce shares up 14% since last earnings report
Salesforce (CRM) is scheduled to report third quarter results after the market close on Wednesday, November 18, with a conference call scheduled for 5:00 pm ET. Salesforce is a provider of enterprise cloud computing solutions that include apps and platform services. EXPECTATIONS: Analysts are looking for earnings per share of 19c on revenue of $1.7B, according to First Call. The consensus range for EPS is 17c-20c on revenue of $1.68B-$1.72B. On its last earnings conference call, Salesforce gave Q3 EPS guidance of 18c-19c and revenue guidance of $1.69B-$1.7B. It also gave FY16 EPS guidance of 70c-72c and FY16 revenue of $6.6B-$6.63B. The company expects FY16 operating cash flow growth of approximately 34%-35%. Salesforce said it is now on pace to reach $7B run rate later this year. LAST QUARTER: On August 20, Salesforce reported second quarter EPS of 19c, beating the consensus analyst forecast of 18c. The company's revenue came in at $1.63B, topping the consensus estimate of $1.60B. It reported deferred revenue on balance of $3.03B as of July 31 and Q2 subscription and support revenue of $1.52B. Salesforce added that Q2 was the "best quarter ever" for the company due to momentum in Europe and growth in the adoption of its core platform. NEWS: Salesforce and Western Union (WU) announced an agreement for Western Union to use Sales Cloud, Community Cloud, Analytics Cloud and App Cloud to automate previously paper-based processes. Salesforce also announced plans to extend its strategic partnership with Microsoft (MSFT). The company said it would double its workforce in the Seattle area. STREET RESEARCH: Brean Capital said Salesforce should be a core holding due its new cloud targets, operating margin expansion and revenue growth in the 20%-30% range year over year. Jeffries said it was impressed with the company's DreamForce conference, but kept an Underperform rating on the stock because the net present value of new business may be negative for Salesforce at this time. In late September, Oppenheimer said that the company's checks were positive. It added that Salesforce's share of the market could be increasing and adds that Salesforce's platform strategy is becoming more popular with customers. PRICE ACTION: Salesforce shares are up over 14% since the company's Q2 report. In afternoon trading ahead of Thursday's report, Salesforce shares are up fractionally.
09:54 EDTWFMWhole Foods says 'bullish' on opportunities to build stores
Subscribe for More Information
08:11 EDTJNJIMS Health forecasts global drug spending to increase 30% by 2020 to $1.4T
Subscribe for More Information
08:11 EDTJNJAduro Biotech receives milestone payment from Janssen
Aduro Biotech (ADRO) announced that it has received a milestone payment from Janssen Biotech (JNJ) for Aduro's submission of an Investigational New Drug, or IND, Application to the FDA for ADU-741, a LADD immunotherapy product candidate for the treatment of prostate cancer. The IND will enable Janssen, Aduro's license partner for ADU-741, to initiate a multi-center Phase 1 trial to evaluate the safety and immunogenicity of intravenous administration of ADU-741 in patients with metastatic castration-resistant prostate cancer.
November 17, 2015
18:58 EDTMSFTMicrosoft CEO says building new cyber defense center, NBC reports
Speaking at the Microsoft Government Cloud Forum on Tuesday, CEO Satya Nadella revealed plans to open a Cyber Defense Operations Center, gathering security experts from across the company's suite of products in order to respond to security threats in real-time, reports NBC. Reference Link
09:14 EDTMDTMedtronic announces FDA approval, launch of MyCareLink Smart Monitor
Subscribe for More Information
09:02 EDTMSFTAnalyst pans competing products, says buy Fitbit
Shares of previous high-flier Fitbit (FIT) have dropped about 30% in the last two weeks following the company's third quarter earnings report, but an analyst at Bank of America upgraded his view of the fitness tracker maker this morning, saying that now is the time to buy ahead of fourth quarter results that may be boosted by the "underwhelming" new products being launched by its competitors. UNDERWHELMING COMPETITION: Fitbit's sales guidance for this holiday quarter looks conservative, contends Bank of America analyst Nat Schindler, who notes that the company only had the launch of one new product last December but will have the Charge, Charge HR and Surge to drive sales this season. Schindler also notes that the company's international advertising has expanded into more countries ahead of the holidays this year. Key, however, may be the "underwhelming" lineup of new or updated fitness trackers launched by competitors, such as the Microsoft's (MSFT) Band 2, Jawbone's UP4 and Sony's (SNE) Smartband 2, many of which have only minor improvements and no "must have" features to pull consumers away from Fitbit, Schindler told investors in his research note. PLATFORM PICKING UP STEAM: The analyst also pointed out that Fitbit now has more than 20 companies signed onto its health and wellness platform, including big names like Target (TGT) and Barclays (BCS), which he believes should help drive revenue beats in the upcoming fiscal year due to increased device sales. Also, the additional dashboard data should help Fitbit maintain long-term user engagement, said Schindler. APPLE WATCH: Apple's (AAPL) Apple Watch is largely viewed as the biggest potential competitive threat to Fitbit's offerings, but on the fitness tracker maker's last earnings call CEO James Park said Fitbit's products differ from those of its competitors in several key aspects, including pricing, cross-platform compatibility, brand awareness and product line breadth. Other wearables makers include Garmin (GRMN) and Samsung. PRICE ACTION: Since the day after Fitbit's last earnings report after the market close on November 2, its shares have fallen about 29.5% to close yesterday at $28.80. In pre-market trading this morning, Fitbit shares rose 2% to $29.40.
08:54 EDTSTMMaxim could be bidder for Fairchild, says Citi
Citi analyst Atif Malik views Maxim Integrated (MXIM) as a potential acquirer Fairchild Semiconductor (FCS). Bloomberg on October 13 reported that Fairchild was seeking advice for a potential sale, and listed potential acquirers as STMicroelectronics (STM), Infineon (IFNNY) and ON Semiconductor (ON). Bids from STM and ON seem unlikely, but Infineon and Maxim could be potential acquirers of Fairchild, Malik tells investors in a research note. In a bull case scenario, Fairchild's buyout value could reach $25 per share, the analyst contends. Fairchild closed yesterday at $17.76. Malik's peer at Citi, analyst Christopher Danely, argued today in research note that Maxim Integrated (MXIM) is unlikely to get acquired despite reports of interest from Analog Devices (ADI) and Texas Instruments (TXN). Danely views Xilinx (XLNX) as a potential takeout target, potentially for Qualcomm (QCOM).
08:10 EDTENBMitsubishi UFJ to hold a conference
Oil & Gas Conference is being held in New York on November 17.
07:56 EDTMSFT, GLWUBS to hold a conference
Global Technology Conference is being held in San Francisco on November 16-18 with webcasted company presentations to begin on November 17 at 10:45 am.; not all company presentations may be webcasted. Webcast Link
06:24 EDTENBEnbridge reduces workforce in Canada, U.S. by 5%, Reuters says
Subscribe for More Information
06:16 EDTMSFTMicrosoft turns around flawed security technology, NY Times says
Subscribe for More Information
November 16, 2015
17:06 EDTOSKOshkosh files automatic mixed securities shelf
Subscribe for More Information
17:02 EDTMSFTPoint72 added to lululemon position, subtracted from Netflix position
Subscribe for More Information
16:00 EDTMSFTOptions Update; November 16, 2015
Subscribe for More Information
14:38 EDTJNJGenmab confirms FDA approval of Darzalex
Subscribe for More Information
13:09 EDTJNJFDA approves Darzalex to treat multiple myeloma
Subscribe for More Information
November 15, 2015
19:29 EDTMSFTMicrosoft delays, possibly kills tool to translate Android apps, Re/code says
Subscribe for More Information
16:12 EDTENBCanadian ban on coastal tanker traffic may impact Enbridge, Bloomberg says
Canada plans to ban oil tanker traffic along British Columbia's northern coast, reports Bloomberg, arguing that the move adds "another hurdle" to Enbridge's proposed Northern Gateway pipeline. Reference Link
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use